Hydroxyethyl starch for cardiovascular surgery: A systematic review of randomized controlled trials

European Journal of Clinical Pharmacology

Volumn 67, Issue 8, 2011, Pages 767-782

  Shi, Xue Yin ^a   Zou, Zui ^a   He, Xing Ying ^a   Xu, Hai Tao ^a   Yuan, Hong Bin ^a   Liu, Hu ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Blood loss; Cardiovascular surgery; Hydroxyethyl starch; Systematic review

Indexed keywords

ALBUMIN; GELATIN; HETASTARCH; PLASMA SUBSTITUTE;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; DRUG SAFETY; HEART SURGERY; HEPATITIS; HOSPITAL INFECTION; HUMAN; JAUNDICE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; META ANALYSIS; MOLECULAR WEIGHT; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PRURITUS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REOPERATION; SURGICAL MORTALITY; SYSTEMATIC REVIEW;

ADULT; AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIOVASCULAR SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; HEMOSTASIS, SURGICAL; HETASTARCH; HUMANS; INFANT; MIDDLE AGED; MOLECULAR WEIGHT; PERIOPERATIVE CARE; PLASMA SUBSTITUTES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79960963668     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1008-5     Document Type: Article

References (88)

1. Laxenaire MC, Charpentier C, Feldman L (1994) Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Rèanim 13(3):301-310 (Pubitemid 24238567)
2. Ford SA, Kam PC, Baldo BA, Fisher MM (2001) Anaphylactic or anaphylactoid reactions in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 15(6):684-688 (Pubitemid 34016101)
3. Nearman HS, Herman ML (1991) Toxic effects of colloids in the intensive care unit. Crit Care Clin 7(3):713-723
4. Treib J, Baron JF, Grauer MT, Strauss RG (1999) An international view of hydroxyethyl starches. Intensive Care Med 25(3):258-268 (Pubitemid 29137610)
5. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT (2009) Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg 108(1):30-36
6. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T (2001) Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth 104(6):691-697
7. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA (1999) Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88(2):312-319 (Pubitemid 29070189)
8. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P (2008) The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 107 (2):382-390
9. Wilkes MM, Navickis RJ, Sibbald WJ (2001) Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 72(2):527-533
10. Traylor RJ, Pearl RG (1996) Crystalloid versus colloid versus colloid: all colloids are not created equal. Anesth Analg 83 (2):209-212 (Pubitemid 26255805)
11. Jungheinrich C, Neff TA (2005) Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 44(7):681-699 (Pubitemid 40994079)
12. Boldt J (2006) Do plasma substitutes have additional properties beyond correcting volume deficits? Shock 25(2):103-116
13. Strauss RGSC, Henriksen RA, Villhauer PJ (1988) Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 28(3):257-260
14. Boldt J, Suttner S, Brosch C, Lehmann A, Rohm K, Mengistu A (2009) Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesth Analg 109(6):1752-1762
15. Pagliaro L, D'Amico G, Sorensen TI, Lebrec D, Burroughs AK, Morabito A, Tine F, Politi F, Traina M (1992) Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med 117(1):59-70
16. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1-12
17. Cheng JW, Wei RL, Cai JP, Xi GL, Zhu H, Li Y, Ma XY (2007) Efficacy of different intraocular lens materials and optic edge designs in preventing posterior capsular opacification: a meta-analysis. Am J Ophthalmol 143(3):428-436
18. Kuitunen A, Suojaranta-Ylinen R, Kukkonen S, Niemi T (2007) A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5) and 4% human albumin after cardiac surgery. Scand J Surg 96(1):72-78 (Pubitemid 46493769)
19. Moiniche S, Mikkelsen S, Wetterslev J, Dahl JB (1998) A qualitative systematic review of incisional local anaesthesia for postoperative pain relief after abdominal operations. Br J Anaesth 81(3):377-383 (Pubitemid 28416617)
20. Cook DJ, Mulrow CD, Haynes RB (1997) Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 126(5):376-380 (Pubitemid 27102522)
21. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH (2006) Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 102(4):998-1006
22. Niemi T, Schramko A, Kuitunen A, Kukkonen S, Suojaranta-Ylinen R (2008) Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. Scand J Surg 97(3):259-265
23. Tigchelaar I, Gallandat Huet RC, Korsten J, Boonstra PW, van Oeveren W (1997) Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg 11(4):626-632 (Pubitemid 27180130)
24. Lumb PD (1987) A comparison between 25% albumin and 6% hydroxyethyl starch solutions on lung water accumulation during and immediately after cardiopulmonary bypass. Ann Surg 206 (2):210-213
25. Dytkowska B, Karwacki Z, Suchorzewska J, Wujtewicz M (1998) Comparative assessment of 200/0.5 HAES 6% and Gelafundin in the treatment of hypovolaemia in post-coronary bypass patients. Med Sci Monit 4(6):CR1000-CR1003
26. Ragaller M, Muller M, Bleyl JU, Strecker A, Segiet TW, Ellinger K, Albrecht DM (2000) Hemodynamic effects of hypertonic hydroxyethyl starch 6% solution and isotonic hydroxyethyl starch 6% solution after declamping during abdominal aortic aneurysm repair. Shock 13(5):367-373
27. Boldt J, Zickmann B, Rapin J, Hammermann H, Dapper F, Hempelmann G (1994) Influence of volume replacement with different HES-solutions on microcirculatory blood flow in cardiac surgery. Acta Anaesthesiol Scand 38(5):432-438 (Pubitemid 24204459)
28. Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dotsch J, Rascher W (2006) Hypertonichyperoncotic solutions improve cardiac function in children after open-heart surgery. Pediatrics 118(1):e76-e84 (Pubitemid 46074626)
29. Khosropour R, Lackner F, Steinbereithner K, Watzek C, Piza F, Wagner O, Amesberger C (1980) Comparison of effects of hydroxyethylstarch (HES 200/0.5) administered pre- and postoperatively in vascular surgery with dextran 40 (60) (author's transl). Anaesthesist 29(11):616-622
30. Diehl JT, Lester JL 3rd, Cosgrove DM (1982) Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Ann Thorac Surg 34(6):674-679 (Pubitemid 13208210)
31. Moggio RA, Rha CC, Somberg ED, Praeger PI, Pooley RW, Reed GE (1983) Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients. Crit Care Med 11(12):943-945 (Pubitemid 14209893)
32. Yen TS, Chan KC (2008) Intraoperative coagulation was more interfered by HES 200/0.5 than normal saline in off-pump coronary artery bypass surgery. J Cardiovasc Surg (Torino) 49 (5):679-684
33. Mythen MG, Webb AR (1995) Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 130(4):423-429
34. Verheij J, van Lingen A, Beishuizen A, Christiaans HM, de Jong JR, Girbes AR, Wisselink W, Rauwerda JA, Huybregts MA, Groeneveld AB (2006) Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med 32(7):1030-1038 (Pubitemid 43952718)
35. Boldt J, Mayer J, Brosch C, Lehmann A, Mengistu A (2010) Volume replacement with a balanced hydroxyethyl starch (HES) preparation in cardiac surgery patients. J Cardiothorac Vasc Anesth 24(3):399-407
36. Boldt J, Brosch C, Rohm K, Papsdorf M, Mengistu A (2008) Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 100 (4):457-464 (Pubitemid 351773609)
37. Mahmood A, Gosling P, Vohra RK (2007) Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 94 (4):427-433 (Pubitemid 46624720)
38. Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P (2008) Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol 25(12):986-994
39. London MJ, Ho JS, Triedman JK, Verrier ED, Levin J, Merrick SH, Hanley FL, Browner WS, Mangano DT (1989) A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 97(5):785-797 (Pubitemid 19123043)
40. Marik PE, Iglesias J, Maini B (1997) Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneurysm repair. J Crit Care 12(2):51-55 (Pubitemid 27246232)
41. Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, Bepperling F (2000) A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 47 (12):1207-1215 (Pubitemid 32098997)
42. Perel P, Roberts I (2007) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev (4):CD000567
43. Bunn F, Trivedi D, Ashraf S (2008) Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev (1):CD001319
44. Hartog CS, Bauer M, Reinhart K (2011) The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg 112 (1):156-164
45. Dart AB, Mutter TC, Ruth CA, Taback SP (2010) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev (1):CD007594
46. Himpe D (2003) Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: a meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg 54(3):207-215
47. Ali MA, Saleh M (2004) Selection of optimal quantity of hydroxyethyl starch in the cardiopulmonary bypass prime. Perfusion 19(1):41-45 (Pubitemid 38386648)
48. Boks RH, Wijers MJ, Hofland J, Takkenberg JJ, Bogers AJ (2007) Low molecular starch versus gelatin plasma expander during CPB: does it make a difference? Perfusion 22(5):333-337
49. Boldt J, von Bormann B, Kling D, Borner U, Mulch J, Hempelmann G (1986) Volume replacement with a new hydroxyethyl starch preparation (3 percent HES 200/0.5) in heart surgery. Infusionsther Klin Ernähr 13(3):145-151
50. Boldt J, Kling D, Zickmann B, Jacobi M, von Bormann B, Dapper F, Hempelmann G (1990) Acute plasmapheresis during cardiac surgery: volume replacement by crystalloids versus colloids. J Cardiothorac Anesth 4(5):564-570 (Pubitemid 20363411)
51. Boldt J, Zickmann B, Ballesteros BM, Stertmann F, Hempelmann G (1992) Influence of five different priming solutions on platelet function in patients undergoing cardiac surgery. Anesth Analg 74 (2):219-225
52. Boldt J,Knothe C, Zickmann B,Andres P,Dapper F,Hempelmann G (1993) Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 76(6):1185-1190
53. Boldt J, Knothe C, Schindler E, Hammermann H, Dapper F, Hempelmann G (1993) Volume replacement with hydroxyethyl starch solution in children. Br J Anaesth 70(6):661-665 (Pubitemid 23169061)
54. Boldt J, Lehmann A, Rompert R, Haisch G, Isgro F (2000) Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass. J Cardiothorac Vasc Anesth 14(3):264-268 (Pubitemid 30415923)
55. Boldt J, Brenner T, Lehmann A, Lang J, Kumle B, Werling C (2003) Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Intensive Care Med 29(5):763-769 (Pubitemid 36609569)
56. Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A (2007) Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 35(12):2740-2746 (Pubitemid 350175770)
57. Boldt J, Brosch C, Rohm K, Lehmann A, Mengistu A, Suttner S (2008) Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function? Anesth Analg 107(5):1496-1503
58. Bruegger D, Bauer A, Rehm M, Niklas M, Jacob M, Irlbeck M, Becker BF, Christ F (2005) Effect of hypertonic saline dextran on acid-base balance in patients undergoing surgery of abdominal aortic aneurysm. Crit Care Med 33(3):556-563 (Pubitemid 40365557)
59. Brutocao D, Bratton SL, Thomas JR, Schrader PF, Coles PG, Lynn AM (1996) Comparison of hetastarch with albumin for postoperative volume expansion in children after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 10(3):348-351 (Pubitemid 26130294)
60. Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL (2010) Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol 76(8):584-591
61. Chong Sung K, Kum Suk P, Mi Ja Y, Kyoung Ok K (2006) Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Acta Anaesthesiol Scand 50(1):108-111 (Pubitemid 43339039)
62. Eising GP, Niemeyer M, Gunther T, Tassani P, Pfauder M, Schad H, Lange R (2001) Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery? Eur J Cardiothorac Surg 20(2):282-289
63. Gallagher JD, Moore RA, Kerns D, Jose AB, Botros SB, Flicker S, Naidech H, Clark DL (1985) Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesth Analg 64(8):753-758 (Pubitemid 15043011)
64. Gold MS, Russo J, Tissot M, Weinhouse G, Riles T (1990) Comparison of hetastarch to albumin for perioperative bleeding in patients undergoing abdominal aortic aneurysm surgery. A prospective, randomized study. Ann Surg 211(4):482-485 (Pubitemid 20138191)
65. Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F (2001) Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 15(3):316-321 (Pubitemid 32553378)
66. Hanart C, Khalife M, De Ville A, Otte F, De Hert S, Van der Linden P (2009) Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. Crit Care Med 37(2):696-701
67. Hecht-Dolnik M, Barkan H, Taharka A, Loftus J (2009) Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial. J Thorac Cardiovasc Surg 138(3):703-711
68. Honkonen EL, Jarvela K, Huhtala H, Holm P, Lindgren L (2009) Hyper osmolality does not modulate natriuretic peptide concentration in patients after coronary artery surgery. Acta Anaesthesiol Scand 53(5):565-572
69. Iriz E, Kolbakir F, Akar H, Adam B, Keceligil HT (2005) Comparison of hydroxyethyl starch and ringer lactate as a prime solution regarding S-100beta protein levels and informative cognitive tests in cerebral injury. Ann Thorac Surg 79(2):666-671 (Pubitemid 40186578)
70. Kasper SM, Meinert P, Kampe S, Gorg C, Geisen C, Mehlhorn U, Diefenbach C (2003) Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 99(1):42-47 (Pubitemid 36799031)
71. Kirklin JK, Lell WA, Kouchoukos NT (1984) Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Ann Thorac Surg 37(1):40-46 (Pubitemid 14218891)
72. Kuitunen A, Hynynen M, Salmenpera M, Heinonen J, Vahtera E, Verkkala K, Myllyla G (1993) Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on haemostasis. Acta Anaesthesiol Scand 37(7):652-658 (Pubitemid 23298999)
73. Kuitunen AH, Hynynen MJ, Vahtera E, Salmenpera MT (2004) Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg 98 (2):291-297 (Pubitemid 38129368)
74. Kvalheim VL, Farstad M, Steien E, Mongstad A, Borge BA, Kvitting PM, Husby P (2009) Infusion of hypertonic saline/starch during cardiopulmonary bypass reduces fluid overload and may impact cardiac function. Acta Anaesthesiol Scand 54(4):485-493
75. Ley SJ, Miller K, Skov P, Preisig P (1990) Crystalloid versus colloid fluid therapy after cardiac surgery. Heart Lung 19(1):31-40 (Pubitemid 20045823)
76. London MJ, Franks M, Verrier ED, Merrick SH, Levin J, Mangano DT (1992) The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial. J Thorac Cardiovasc Surg 104(2):284-296
77. Magder S, Potter BJ, Varennes BD, Doucette S, Fergusson D (2010) Fluids after cardiac surgery: a pilot study of the use of colloids versus crystalloids. Crit Care Med 38(11):2117-2124
78. Mastroianni L, Low HB, Rollman J, Wagle M, Bleske B, Chow MS (1994) A comparison of 10% pentastarch and 5% albumin in patients undergoing open-heart surgery. J Clin Pharmacol 34 (1):34-40 (Pubitemid 24050363)
79. Munsch CM, MacIntyre E, Machin SJ, Mackie IJ, Treasure T (1988) Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. Br J Surg 75 (7):675-678
80. Ooi JS, Ramzisham AR, Zamrin MD (2009) Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery? Asian Cardiovasc Thorac Ann 17(4):368-372
81. Sade RM, Stroud MR, Crawford FA Jr, Kratz JM, Dearing JP, Bartles DM (1985) A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 89 (5):713-722 (Pubitemid 16241964)
82. Sirvinskas E, Sneider E, Svagzdiene M, Vaskelyte J, Raliene L, Marchertiene I, Adukauskiene D (2007) Hypertonic hydroxyethyl starch solution for hypovolaemia correction following heart surgery. Perfusion 22(2):121-127 (Pubitemid 47162373)
83. Tigchelaar I, Gallandat Huet RC, Boonstra PW, van Oeveren W (1998) Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients. Perfusion 13(5):297-303 (Pubitemid 28423243)
84. Tiryakioglu O, Yildiz G, Vural H, Goncu T, Ozyazicioglu A, Yavuz S (2008) Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial). J Cardiothorac Surg 3:45
85. Van der Linden PJ, De Hert SG, Daper A, Trenchant A, Schmartz D, Defrance P, Kimbimbi P (2004) 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anaesth 51(3):236-241 (Pubitemid 39022427)
86. Van der Linden PJ, De Hert SG, Deraedt D, Cromheecke S, De Decker K, De Paep R, Rodrigus I, Daper A, Trenchant A (2005) Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 101 (3):629-634 (Pubitemid 41208482)
87. Vanhoonacker J, Ongenae M, Vanoverschelde H, Donadoni R (2009) Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG. Acta Anaesthesiol Belg 60(2):91-97
88. Yap WW, Young D, Pathi V (2007) Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass-a randomised controlled trial. Perfusion 22(1):57-61